ZYDUSLIFE - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.3
| Stock Code | ZYDUSLIFE | Market Cap | 89,585 Cr. | Current Price | 890 ₹ | High / Low | 1,059 ₹ |
| Stock P/E | 19.1 | Book Value | 215 ₹ | Dividend Yield | 1.24 % | ROCE | 30.6 % |
| ROE | 31.1 % | Face Value | 1.00 ₹ | DMA 50 | 907 ₹ | DMA 200 | 934 ₹ |
| Chg in FII Hold | -0.28 % | Chg in DII Hold | 0.22 % | PAT Qtr | 343 Cr. | PAT Prev Qtr | 1,157 Cr. |
| RSI | 45.6 | MACD | -4.07 | Volume | 4,49,651 | Avg Vol 1Wk | 5,58,419 |
| Low price | 795 ₹ | High price | 1,059 ₹ | PEG Ratio | 0.26 | Debt to equity | 0.35 |
| 52w Index | 36.2 % | Qtr Profit Var | -27.2 % | EPS | 46.2 ₹ | Industry PE | 27.2 |
📊 ZYDUSLIFE shows moderate potential for intraday trading today. Current price (₹890) is below both 50 DMA (₹907) and 200 DMA (₹934), reflecting short-term weakness. RSI at 45.6 indicates neutral momentum, while MACD (-4.07) suggests mild bearish undertones. Volume today (4.49 lakh) is lower than the weekly average (5.58 lakh), showing reduced participation. Fundamentals remain strong, but recent profit decline limits upside intraday momentum.
- 💰 Optimal Buy Price: ₹885–₹895 (near support zone)
- 📈 Profit-Taking Levels: ₹905–₹920 (short-term resistance)
- 📉 Stop-Loss: ₹875 (below immediate support)
- ⏳ If Already Holding: Exit if price fails to sustain above ₹900 with weakening momentum or if intraday volume continues to decline.
✅ Positive
- Strong ROCE (30.6%) and ROE (31.1%) highlight excellent efficiency.
- EPS of ₹46.2 shows solid profitability.
- PEG ratio (0.26) indicates attractive growth valuation.
- Dividend yield (1.24%) adds investor appeal.
- Book value (₹215) provides valuation cushion.
⚠️ Limitation
- Stock trading below both 50 DMA and 200 DMA reflects bearish sentiment.
- Quarterly PAT declined sharply (₹343 Cr. vs ₹1,157 Cr.).
- Volume below weekly average reduces intraday momentum strength.
📉 Company Negative News
- Quarterly profit variation (-27.2% YoY) highlights earnings pressure.
- Decline in FII holding (-0.28%) shows reduced foreign investor confidence.
📈 Company Positive News
- DII holding increased (+0.22%), reflecting domestic investor support.
- Strong efficiency metrics (ROCE and ROE) support long-term fundamentals.
🏭 Industry
- Industry P/E (27.2) is higher than company’s (19.1), suggesting ZYDUSLIFE is undervalued relative to peers.
- Pharma sector outlook remains strong with steady demand for healthcare products.
🔎 Conclusion
ZYDUSLIFE offers cautious intraday opportunities with strong fundamentals and undervaluation relative to peers, but weak technical indicators and profit decline limit upside. Traders may consider entries near ₹885–₹895 with tight stop-losses and aim for exits around ₹905–₹920. Best suited for conservative intraday trades rather than aggressive momentum plays.